Carlsmed pioneers AI-enabled personalized spine surgery solutions through its aprevo platform, which creates patient-specific surgical plans and custom fusion devices matched to individual anatomy and alignment. The medical technology company integrates proprietary AI software with digital manufacturing processes to produce tailored implants for spine fusion procedures. It serves spine surgeons and patients by aiming to improve precision, outcomes, and efficiency in surgical care.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 12.1 | — | -6.8 | — |
| Q3 2025 | 13.1 | — | -8.5 | — |
| Q4 2025 | 15.2 | — | -8.6 | — |
| Q1 2026 | 16.1 | — | -8.7 | — |
| Q2 2026 | 18.9 | 56.8% | -10.5 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Algoma Steel Group Inc. (ASTL), Innovative Aerosystems, Inc. (ISSC), Q32 Bio Inc. (QTTB), 908 Devices Inc. (MASS), First Bank (FRBA), Prenetics Global Limited (PRE)